Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on June 24, 2025
Rapid7 Puts Agentic AI to Work in the SOC, Empowering Analysts to Investigate Smarter and Faster
GlobeNewswire
·
June 24, 2025
BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Today, Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, announced that agentic AI workflows are now embedded within Rapid7’s next-gen SIEM and XDR platform to fundamentally change …
Access Recognized on Boston Business Journal’s Largest Private Companies in Massachusetts List for Third Consecutive Year
GlobeNewswire
·
June 24, 2025
PEABODY, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Access, the world’s largest privately-held integrated information management services provider, announced today that it has been named once again to the Boston Business Journal’s (BBJ) prestigious annual …
AI at Work: New Global Study Links AI to Greater Happiness
GlobeNewswire
·
June 24, 2025
Workers who use AI daily are 34% more satisfied with their jobs and feel more optimistic about the future. Job satisfaction strongly influences life satisfaction with happy employees 4.5 times more likely to feel happy in life. AI users report higher …
Ernexa Therapeutics Secures $6 Million in Second Closing Under Securities Purchase Agreement
GlobeNewswire
·
June 24, 2025
CAMBRIDGE, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that the Company completed the second closing under …
Byrna Technologies to Report Fiscal Second Quarter 2025 Financial Results on Thursday, July 10, 2025 at 9:00 a.m. ET
GlobeNewswire
·
June 24, 2025
ANDOVER, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security …
Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome
GlobeNewswire
·
June 24, 2025
First-ever mini-Heart models will be created from hypoplastic left heart syndrome (HLHS) patient stem cells, enabling personalized insights into their causes and treatments Partnership aims to improve survival and quality of life for pediatric HLHS …
Report Reveals Candidates’ Perspectives on Using AI in the Hiring Process
GlobeNewswire
·
June 24, 2025
DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- In today’s high-pressure hiring environment, where talent teams are expected to do more with less, Employ Inc. remains committed to delivering innovative, intelligent hiring solutions that meet the real-world needs …
Agilitas Energy Expands into Hydropower with Acquisition of Two Projects in West Virginia and Maryland
GlobeNewswire
·
June 24, 2025
WAKEFIELD, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Agilitas Energy, a leading developer and operator of renewable energy and energy storage systems, today announced the acquisition of two late-stage hydropower development projects from Advanced Hydro …
Pickle Robot Hires New VP of Engineering, Adding 50 New Engineers by September as Warehouse Robotics Demand Surges
GlobeNewswire
·
June 24, 2025
CAMBRIDGE, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Pickle Robot, the pioneer in Physical AI automation for the supply chain, today announced Fred Hopke as its new Vice President of Engineering and unveiled plans to hire 50 additional engineers over the …
Atea Pharmaceuticals Announces Continued Advancement of Global Phase 3 HCV Program with Dosing of First Patient in C-FORWARD Outside North America
GlobeNewswire
·
June 24, 2025
C-FORWARD is the Second Phase 3 Trial in the Global HCV Development Program; the First Phase 3 Trial, C-BEYOND, is Currently Enrolling Patients in the US and Canada Regimen has Potential Best-in-Class Profile with Short Treatment Duration, Low Risk for …